Important Safety Information: Compounded semaglutide is not FDA-approved
Transition plan to insulin / discontinuing GLP-1 RA
A diferencia de otros medicamentos, solo requiere una inyeccin subcutneo una vez a la semana (la mayora consisten en aplicaciones diarias), por lo que resulta conveniente
The causes of Addisons disease include tuberculosis, fungal infection, idiopathic adrenal atrophy, tumor metastasis, and amyloidosis
Liraglutide, dulaglutide, semaglutide, and tirzepatide do not require dose adjustment based on renal function, though patients with impaired kidney function should be monitored for potential dehydration-related renal events